Insider Trading History of Polymeropoulos Mihael Hristos

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Polymeropoulos Mihael Hristos since 2015. This trader's CIK number is 1355537. At the time of last reporting, Polymeropoulos Mihael Hristos was the President and CEO of Vanda Pharmaceuticals Inc.. (stock ticker symbol VNDA). Also see all insider trading activities at Vanda Pharmaceuticals Inc..



Yearly summary of insider trading at Vanda Pharmaceuticals Inc. (VNDA) by Polymeropoulos Mihael Hristos

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 VNDA 0 $0 156,235 $1,276,908 0 $0
2025 VNDA 90,000 $420,338 0 $0 0 $0
2024 VNDA 0 $0 55,172 $231,356 0 $0
2023 VNDA 0 $0 44,964 $280,598 0 $0
2022 VNDA 0 $0 37,096 $413,949 0 $0
2021 VNDA 0 $0 293,885 $5,130,548 150,000 $731,999
2020 VNDA 0 $0 150,299 $1,951,740 150,000 $1,312,499
2019 VNDA 0 $0 419,826 $7,027,792 425,000 $5,001,248
2018 VNDA 0 $0 252,726 $4,074,138 293,750 $423,000
2017 VNDA 0 $0 23,330 $361,241 50,000 $0
2016 VNDA 0 $0 21,353 $191,322 43,750 $0
2015 VNDA 0 $0 340,034 $3,832,372 677,898 $1,033,001


Insider trading of Vanda Pharmaceuticals Inc. (VNDA) by Polymeropoulos Mihael Hristos

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-03-02 VNDA Sale 156,235 8.17 1,276,908
2025-08-07 VNDA Buy 10,000 4.15 41,500
2025-05-21 VNDA Buy 10,000 4.39 43,949
2025-03-06 VNDA Buy 10,000 5.01 50,150
2025-03-05 VNDA Buy 10,000 5.02 50,199
2025-03-03 VNDA Buy 10,000 4.71 47,050
2025-02-28 VNDA Buy 10,000 4.76 47,600
2025-02-27 VNDA Buy 10,000 4.76 47,600
2025-02-26 VNDA Buy 10,000 4.76 47,650
2025-02-25 VNDA Buy 10,000 4.46 44,640
2024-03-04 VNDA Sale 30,884 4.24 131,071
2024-03-05 VNDA Sale 24,288 4.13 100,285
2023-03-02 VNDA Sale 22,426 6.23 139,713
2023-03-03 VNDA Sale 22,538 6.25 140,885
2022-03-02 VNDA Sale 29,588 11.15 329,935
2022-03-01 VNDA Sale 7,508 11.19 84,014
2021-11-30 VNDA Sale 50,000 16.49 824,300
2021-12-01 VNDA Sale 46,200 16.00 739,338
2021-11-30 VNDA Option Ex 78,324 4.88 382,221
2021-12-01 VNDA Option Ex 71,676 4.88 349,778
2021-03-08 VNDA Sale 175,000 18.00 3,150,000
2021-03-01 VNDA Sale 7,479 18.45 138,002
2021-03-02 VNDA Sale 15,206 18.34 278,908
2020-12-15 VNDA Sale 39,150 13.00 508,832
2020-12-14 VNDA Sale 51,049 13.19 673,285
2020-12-15 VNDA Option Ex 46,663 8.75 408,301
2020-12-14 VNDA Option Ex 61,520 8.75 538,300
2020-12-11 VNDA Option Ex 41,817 8.75 365,898
2020-12-11 VNDA Sale 35,053 12.88 451,377
2020-03-02 VNDA Sale 10,428 10.57 110,213
2020-03-03 VNDA Sale 5,152 10.97 56,543
2020-01-02 VNDA Sale 9,467 16.00 151,490
2019-12-12 VNDA Option Ex 85,801 10.65 913,780
2019-12-11 VNDA Sale 72,373 16.92 1,224,406
2019-12-12 VNDA Sale 70,036 16.98 1,189,351
2019-12-11 VNDA Option Ex 89,199 10.65 949,969
2019-05-17 VNDA Option Ex 97,373 12.55 1,222,031
2019-05-20 VNDA Sale 67,418 15.12 1,019,090
2019-05-21 VNDA Sale 72,872 15.34 1,117,929
2019-05-21 VNDA Option Ex 79,019 12.55 991,688
2019-05-20 VNDA Option Ex 73,608 12.55 923,780
2019-05-17 VNDA Sale 77,225 15.56 1,201,698
2019-03-01 VNDA Sale 6,500 20.22 131,423
2019-03-04 VNDA Sale 38,166 19.41 740,802
2019-01-02 VNDA Sale 10,789 26.63 287,289
2019-01-03 VNDA Sale 4,447 26.04 115,804
2018-03-01 VNDA Sale 60,966 18.71 1,140,978
2018-01-02 VNDA Sale 191,760 15.30 2,933,160
2018-01-02 VNDA Option Ex 293,750 1.44 423,000
2017-01-03 VNDA Option Ex 50,000 .00 0
2017-01-03 VNDA Sale 23,330 15.48 361,241
2016-01-04 VNDA Option Ex 43,750 .00 0
2016-01-04 VNDA Sale 21,353 8.96 191,322
2015-09-10 VNDA Sale 102,162 12.73 1,300,522
2015-09-09 VNDA Sale 29,577 12.51 369,978
2015-09-10 VNDA Option Ex 147,626 4.73 698,270
2015-09-09 VNDA Option Ex 42,747 4.73 202,193
2015-05-21 VNDA Option Ex 35,806 .33 11,851
2015-05-22 VNDA Option Ex 359,815 .33 119,098
2015-05-21 VNDA Sale 17,157 10.33 177,283
2015-05-22 VNDA Sale 169,238 10.36 1,753,982
2015-03-10 VNDA Option Ex 43,750 .00 0
2015-03-10 VNDA Sale 21,900 10.53 230,607
2015-02-05 VNDA Option Ex 48,154 .03 1,589

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Polymeropoulos Mihael Hristos (President and CEO of Vanda Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.